Skip to main content

Table 1 Sequencing reads across patient timeline for UK2 and also comparative data from selected EMLab patients (IDs 413, 753, 578, 462 and 351).

From: Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care

 

Plasma

Blood

Day 1

Day 4

Day 5

Day 6

Day 7

Day 8

Day 9

Day 10

Day 11

Day 12

Total reads

13,431,416

3,833,134

2,645,578

2,177,628

5,431,570

5,705,462

1,864,628

3,049,104

1,481,988

4,342,832

Reads mapped to EBOV

595 (0.00%)

54,856 (1.43%)

1,037,421 (39.21%)

1,198,007 (55.01%)

914,490 (16.84%)

692,250 (12.13%)

116,405 (6.24%)

65,188 (2.14%)

21,352 (1.44%)

25,429 (0.59%)

Reads mapped to human

12,555,014 (93.47%)

1,436,018 (37.5%)

862,860 (32.6%)

519,467 (23.9%)

3,116,172 (57.4%)

3,487,829 (61.1%)

1,239,462 (66.5%)

1,980,054 (64.9%)

916,534 (61.8%)

2,736,038 (63%)

 

Plasma Month 10

CSF

Month 10

071015

CSF

Month 10

081015

 

EMLab

Patient ID

413

753

578

462

351

Total reads

14,377,682

11,626,808

12,774,412

 

Total reads

56,565,350

6,398,890

78,423,238

47,990,570

75,648,710

Reads mapped to EBOV

180 (0.00%)

9227 (0.08%)

10,200 (0.08%)

 

Reads mapped to EBOV

20,471,809 (36.19%)

1,099,593 (17.18%)

7,544,790 (9.62%)

4,469,920 (9.31%)

5,525,548 (7.30%)

Reads mapped to human

13,590,746 (94.53%)

11,073,317 (95.24%)

12,164,725 (95.23%)

 

Reads mapped to human

33,939,691 (60.00%)

4,853,256 (75.85%)

69,922,793 (89.16%)

42,888,768 (89.37%)

68,391,308 (90.41%)